Paper31433674
Equivalent 10-Year Outcomes After Implantation of Autologous Bone Marrow-Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation for Chondral Defects of the Knee.
Teo AQA and 6 others. Am J Sports Med, 2019. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Equivalent 10-Year Outcomes After Implantation of Autologous Bone Marrow-Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation for Chondral Defects of the Knee. Papers, record 31433674. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31433674
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Equivalent 10-Year Outcomes After Implantation of Autologous Bone Marrow-Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation for Chondral Defects of the Knee.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cartilage, Articular | Major topic |
| Chondrocytes | Major topic |
| Knee Injuries | Major topic |
| Mesenchymal Stem Cell Transplantation | Major topic |
| Adult | |
| Bone Marrow Cells | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Lysholm Knee Score | |
| Male | |
| Middle Aged | |
| Orthopedic Procedures | |
| Patient Reported Outcome Measures | |
| Transplantation, Autologous |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40343207 | Mesenchymal stem cells and their extracellular vesicles: new therapies for cartilage repair. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40343207 | PubMed |
| 40297070 | Revision Surgery Is the Most Common Definition of Failure in Studies Evaluating Knee Cartilage Restoration Outcomes: A Systematic Review. | Arthrosc Sports Med Rehabil | 2025 | https://conductscience.org/library/papers/40297070 | PubMed |
| 39408956 | Comparative Analysis of Serum and Serum-Free Medium Cultured Mesenchymal Stromal Cells for Cartilage Repair. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39408956 | PubMed |
| 39285485 | Metabolic modulation to improve MSC expansion and therapeutic potential for articular cartilage repair. | Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/39285485 | PubMed |
| 38921522 | Laser Ablation Facilitates Implantation of Dynamic Self-Regenerating Cartilage for Articular Cartilage Regeneration. | J Funct Biomater | 2024 | https://conductscience.org/library/papers/38921522 | PubMed |
| 38891122 | Mesenchymal Stem Cell-Based Therapies for Temporomandibular Joint Repair: A Systematic Review of Preclinical Studies. | Cells | 2024 | https://conductscience.org/library/papers/38891122 | PubMed |
| 38596189 | Does progress in microfracture techniques necessarily translate into clinical effectiveness? | World J Orthop | 2024 | https://conductscience.org/library/papers/38596189 | PubMed |
| 37853672 | Treatment of Articular Cartilage Defects: A Descriptive Analysis of Clinical Characteristics and Global Trends Reported from 2001 to 2020. | Cartilage | 2024 | https://conductscience.org/library/papers/37853672 | PubMed |
| 37765301 | Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37765301 | PubMed |
| 37360195 | Current and Novel Therapeutics for Articular Cartilage Repair and Regeneration. | Ther Clin Risk Manag | 2023 | https://conductscience.org/library/papers/37360195 | PubMed |
| 37061744 | A systematic review, umbrella review, and quality assessment on clinical translation of stem cell therapy for knee osteoarthritis: Are we there yet? | Stem Cell Res Ther | 2023 | https://conductscience.org/library/papers/37061744 | PubMed |
| 37024929 | Sex-dependent variation in cartilage adaptation: from degeneration to regeneration. | Biol Sex Differ | 2023 | https://conductscience.org/library/papers/37024929 | PubMed |
| 36925544 | MSCs-laden silk Fibroin/GelMA hydrogels with incorporation of platelet-rich plasma for chondrogenic construct. | Heliyon | 2023 | https://conductscience.org/library/papers/36925544 | PubMed |
| 36232468 | Strategies to Convert Cells into Hyaline Cartilage: Magic Spells for Adult Stem Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36232468 | PubMed |
| 35854056 | Treatment of knee cartilage by cultured stem cells and three dimensional scaffold: a phase I/IIa clinical trial. | Int Orthop | 2023 | https://conductscience.org/library/papers/35854056 | PubMed |
| 35722390 | Treatment and application of stem cells from different sources for cartilage injury: a literature review. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/35722390 | PubMed |
| 35326468 | Retrospective Analysis of Autologous Chondrocyte-Based Cytotherapy Production for Clinical Use: GMP Process-Based Manufacturing Optimization in a Swiss University Hospital. | Cells | 2022 | https://conductscience.org/library/papers/35326468 | PubMed |
| 34589487 | A Comprehensive Analysis of SE-lncRNA/mRNA Differential Expression Profiles During Chondrogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34589487 | PubMed |
| 34577930 | Safety and Efficacy of Kartigen® in Treating Cartilage Defects: A Randomized, Controlled, Phase I Trial. | Polymers (Basel) | 2021 | https://conductscience.org/library/papers/34577930 | PubMed |
| 34435068 | Tendon-Derived Progenitor Cells With Multilineage Potential Are Present Within Human Patellar Tendon. | Orthop J Sports Med | 2021 | https://conductscience.org/library/papers/34435068 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31433674
GET https://conductscience.org/api/papers/v1/31433674/cited_by?page=2